2 ASX shares liked by this top fund manager

Australian Clinical Labs is one of the ASX shares that is liked by WAM.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The fund manager Wilson Asset Management (WAM) has told investors about two ASX shares that it has in its portfolio.

WAM operates several listed investment companies (LICs). Some focus on larger companies like WAM Leaders Ltd (ASX: WLE).

There's also one called WAM Capital Limited (ASX: WAM) which targets "the most compelling undervalued growth opportunities in the Australian market."

The WAM Capital portfolio has delivered an investment return of 16.5% per annum since inception in August 1999, before fees, expenses and taxes. This gross return outperformed the S&P/ASX All Ordinaries Accumulation Index return of 8.7% per annum over the same timeframe.

These are the two ASX shares that WAM Capital outlined in its most recent monthly update:

asx investor daydreaming about US shares

Image source: Getty Images

Australian Clinical Labs Ltd (ASX: ACL)

WAM explained that Australian Clinical Labs is a healthcare business that provides pathology services in Australia. It has 86 accredited laboratories which provide services for more than 8 million people and 90 public and private hospitals.

The fund manager noted that the ASX share traded below its initial listing price after listing a few months ago. However, WAM reckons the market didn't understand its earnings power because the focus had been on automating systems and processes, coupled with increased levels of COVID-19 testing – the Australian Clinical Labs share price grew 14.1% during the month.

Why does WAM like the business now? It thinks the company will be able to increase its market share, which can be aided by earnings accretive acquisitions with its balance sheet.

The fund manager points out that Australian Clinical Labs was valued at an approximate 30% discount compared to its peers. This could change if the business can deliver the potential superior organic growth rates and successful acquisitions that WAM is expecting. This could lead to a re-rating of the business.

Select Harvests Limited (ASX: SHV)

The other ASX share that WAM currently likes is the leading almond producer Select Harvests. It is one of the largest growers in Australia.

WAM points out that Select Harvests has already benefited from "considerable growth" in Australian almond production and consumption in the last decade.

Australia is now the second biggest producer of almonds in the world, after the US.

One of the things that WAM noticed from a recent Select Harvests update was that there is growing demand for almonds with Australian almond exports up 67% on the prior period.

The almond business is also seeing higher market prices for its commodity. A downgrade of the US 2021 crop harvest is helping drive an increase in the overall market price for almonds by $0.50 per kilo to a range of $6.75 per kilo to $7.25 per kilo.

Wilson Asset Management believes that almond prices are set to stage a "multi-year recovery" which will help Select Harvests with its increased ownership of almond farms after the Piangil Orchard acquisition in October 2020.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Share Market News

Here's what Westpac says the RBA will do with interest rates next week

Will the central bank hike rates? All signs point to yes.

Read more »

A man clenches his fists in excitement as gold coins fall from the sky.
Broker Notes

Ord Minnett tips these ASX All Ords shares to rise 30% to 50%

Let's see what the broker is recommending to clients.

Read more »

Five young people sit in a row having fun and interacting with their mobile phones.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors ended the trading week on a sour note today.

Read more »

Three people in a corporate office pour over a tablet, ready to invest.
Share Market News

Dalrymple Bay Infrastructure successfully issues inaugural A$350m medium-term note

Dalrymple Bay Infrastructure has priced a $350 million inaugural note to boost funding flexibility and support its asset base.

Read more »

A man casually dressed looks to the side in a pensive, thoughtful manner with one hand under his chin, holding a mobile phone in his hand while thinking about something.
Broker Notes

Buy, hold, sell: DBI, GQG Partners, and Rio Tinto shares

Here's what the broker is saying about these shares.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Share Gainers

3 ASX 200 stocks storming higher in this week's slumping market

These three ASX 200 stocks have gained 10% to more than 25% this week despite the broader market retrace. Here’s…

Read more »

Business man at desk looking out window with his arms behind his head at a view of the city and stock trends overlay.
Broker Notes

Brokers name 3 ASX shares to buy today

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why CAR Group, Immutep, Northern Star, and Syrah Resources shares are sinking today

These shares are ending the week in the red? Here's why.

Read more »